Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder
- PMID: 23255304
- PMCID: PMC3904300
- DOI: 10.1002/ajmg.b.32108
Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder
Abstract
Bipolar disorder (BD) and attention deficit hyperactivity disorder (ADHD) exhibit remarkably high rates of comorbidity, as well as patterns of familial co-segregation. Epidemiological data suggests that these disorders either share a common genetic architecture or that ADHD features in BD may represent an etiologically distinct subtype. We previously used the Wender Utah Rating Scale (WURS) to assess ADHD features in BD families and identified three heritable factors relating to impulsivity, mood instability, and inattention. Linkage analysis revealed a LOD score of 1.33 for the inattention factor on 5p15.3 near the dopamine transporter gene (DAT1), which has been associated with both BD and ADHD. Pharmacological evidence also suggests a role for DAT in both disorders. We have now evaluated the association of ten DAT1 variants for the WURS total score and factors in an overlapping sample of 87 BD families. Significant associations for three SNPs were observed across the WURS measures, notably for a SNP in intron 8 with the WURS total score (P = 0.007) and for variants in introns 9 and 13 with mood instability (P = 0.009 and 0.004, respectively). Analysis of an independent sample of 52 BD cases and 46 healthy controls further supported association of the intron 8 variant with mood instability (P = 0.005), and a combined analysis confirmed the associations of this SNP with WURS total score. Impulsivity and mood instability (P = 0.002, 0.007, and 8 × 10(-4), respectively). These data suggest that variants within DAT1 may predispose to a subtype of BD characterized by early prodromal features that include attentional deficits.
Copyright © 2012 Wiley Periodicals, Inc.
Conflict of interest statement
Drs. Greenwood, Joo, Kelsoe, Remick, and Sadovnick and Ms. Shekhtman have no competing financial interests to report. Dr. McElroy is a consultant to or member of the scientific advisory board of Alkernes, Eli Lilly, and Shire and has received unrelated research support from the Agency for Healthcare Research & Quality (AHRQ), Alkernes, AstraZeneca, Bristol-Myers Squibb, Cephalon, Eli Lilly, Forest Labs, GalaxoSmith Kline, Jazz Pharmaceuticals, Marriott Foundation, Orexigen Therapeutics, Shire, and Takeda Pharmaceutical Company. Dr. McElroy is also an inventor on United States Patent No. 6,323,236 B2 for the use of sulfamate derivatives for treating impulse control disorders and has received payments from Johnson & Johnson Pharmaceutical Research and Development, which has exclusive rights under the patent. Dr. Keck is a co-inventor on a United States Patent (No. 6,387,956) for treating obsessive-compulsive spectrum disorder through tramadol and has received no financial gain.
Figures

Similar articles
-
Association between the dopamine transporter gene (DAT1) and attention deficit hyperactivity disorder-related traits in healthy adults.Psychiatr Genet. 2015 Jun;25(3):119-26. doi: 10.1097/YPG.0000000000000086. Psychiatr Genet. 2015. PMID: 25915480
-
Suggestive evidence for linkage of ADHD features in bipolar disorder to chromosome 10p14.Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):260-8. doi: 10.1002/ajmg.b.31005. Am J Med Genet B Neuropsychiatr Genet. 2010. PMID: 19603423
-
Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples.Mol Psychiatry. 2006 Feb;11(2):125-33, 115. doi: 10.1038/sj.mp.4001764. Mol Psychiatry. 2006. PMID: 16261167 Clinical Trial.
-
[Attention-deficit hyperactivity disorder or bipolar disorder in childhood?].Psychiatriki. 2012 Oct-Dec;23(4):304-13. Psychiatriki. 2012. PMID: 23399752 Review. Greek, Modern.
-
[Heritability and genetic comorbidity of attention deficit disorder with hyperactivity].Rev Med Chil. 2017 Mar;145(3):368-372. doi: 10.4067/S0034-98872017000300011. Rev Med Chil. 2017. PMID: 28548194 Review. Spanish.
Cited by
-
The Influence of 5-HTTLPR, BDNF Rs6265 and COMT Rs4680 Polymorphisms on Impulsivity in Bipolar Disorder: The Role of Gender.Genes (Basel). 2022 Mar 9;13(3):482. doi: 10.3390/genes13030482. Genes (Basel). 2022. PMID: 35328036 Free PMC article.
-
Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.Neurochem Int. 2014 Jul;73:56-70. doi: 10.1016/j.neuint.2013.11.009. Epub 2013 Dec 8. Neurochem Int. 2014. PMID: 24332984 Free PMC article. Review.
-
Neuron membrane trafficking and protein kinases involved in autism and ADHD.Int J Mol Sci. 2015 Jan 30;16(2):3095-115. doi: 10.3390/ijms16023095. Int J Mol Sci. 2015. PMID: 25647412 Free PMC article. Review.
-
Application of Research Domain Criteria to childhood and adolescent impulsive and addictive disorders: Implications for treatment.Clin Psychol Rev. 2018 Aug;64:41-56. doi: 10.1016/j.cpr.2016.11.003. Epub 2016 Nov 9. Clin Psychol Rev. 2018. PMID: 27876165 Free PMC article. Review.
-
The molecular genetic architecture of attention deficit hyperactivity disorder.Mol Psychiatry. 2015 Mar;20(3):289-97. doi: 10.1038/mp.2014.183. Epub 2015 Jan 20. Mol Psychiatry. 2015. PMID: 25600112 Review.
References
-
- Angrist B. Clinical variations of amphetamine psychosis. In: Cho AK, Segal DS, editors. Amphetamine and Its Analogs. San Diego: Academic Press; 1994. pp. 387–414.
-
- Asherson P, Brookes K, Franke B, Chen W, Gill M, Ebstein RP, Buitelaar J, Banaschewski T, Sonuga-Barke E, Eisenberg J, et al. Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. Am J Psychiatry. 2007;164(4):674–677. - PubMed
-
- Barr CL, Xu C, Kroft J, Feng Y, Wigg K, Zai G, Tannock R, Schachar R, Malone M, Roberts W, et al. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder. Biol Psychiatry. 2001;49(4):333–339. - PubMed
-
- Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263–265. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 MH078151/MH/NIMH NIH HHS/United States
- K01-MH087889/MH/NIMH NIH HHS/United States
- R01 MH094483/MH/NIMH NIH HHS/United States
- MH30914/MH/NIMH NIH HHS/United States
- M01 RR000827/RR/NCRR NIH HHS/United States
- MH078151/MH/NIMH NIH HHS/United States
- K01 MH087889/MH/NIMH NIH HHS/United States
- R01 MH059567/MH/NIMH NIH HHS/United States
- MH47612/MH/NIMH NIH HHS/United States
- M01 RR00827/RR/NCRR NIH HHS/United States
- R01 MH068503/MH/NIMH NIH HHS/United States
- MH68503/MH/NIMH NIH HHS/United States
- MH59567/MH/NIMH NIH HHS/United States